Pulmonary arterial hypertension (adults) – drugs: Appraisal consultation document (3rd March 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil. Closing date for comments is 20th March 2008)
Click here for the Consultation
Pregnancy (rhesus negative women) – routine anti-D: Appraisal consultation document (7th March 2008)
The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of routine antenatal anti-D prophylaxis for women who are RhD negative (review of NICE technology appraisal guidance 41) and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of routine antenatal anti-D prophylaxis for women who are RhD negative. Closing date for comments is 1st April 2008.
Click here for the Consultation
Respiratory tract infections guideline: consultation (11th March 2008)
A clinical practice guideline on Respiratory tract infections is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for the Respiratory tract infections guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 8th April 2008.
Click here for the Full guideline
Click here for the Appendices to full version
Click here for the Comments proforma
Chronic kidney disease: consultation (11th March 2008)
A clinical practice guideline on Chronic Kidney Disease is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 11th March 2008.
Click here for the Full guideline
Click here for the NICE guideline
Click here for the Evidence tables
Click here for the Comments proforma
Cochlear implants: 2nd appraisal consultation document (14th March 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of cochlear implants for children and adults with severe to profound deafness, and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of cochlear implants. Closing date for comments is 8th April 2008.
Click here for the Consultation
Prophylaxis against infective endocarditis – Clinical Guideline CG64 (17th March 2008)
This guidance covers the protection of patients who are at risk of infective endocarditis, specifically adults and children or who have previously had infective endocarditis. It also covers people at risk because of medical procedures.
Click here for the NICE Guidance
Click here for the Appendices
Click here for the Quick Reference Guide
Click here for Understanding NICE
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil. Closing date for comments is 20th March 2008)
Click here for the Consultation
Pregnancy (rhesus negative women) – routine anti-D: Appraisal consultation document (7th March 2008)
The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of routine antenatal anti-D prophylaxis for women who are RhD negative (review of NICE technology appraisal guidance 41) and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of routine antenatal anti-D prophylaxis for women who are RhD negative. Closing date for comments is 1st April 2008.
Click here for the Consultation
Respiratory tract infections guideline: consultation (11th March 2008)
A clinical practice guideline on Respiratory tract infections is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for the Respiratory tract infections guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 8th April 2008.
Click here for the Full guideline
Click here for the Appendices to full version
Click here for the Comments proforma
Chronic kidney disease: consultation (11th March 2008)
A clinical practice guideline on Chronic Kidney Disease is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 11th March 2008.
Click here for the Full guideline
Click here for the NICE guideline
Click here for the Evidence tables
Click here for the Comments proforma
Cochlear implants: 2nd appraisal consultation document (14th March 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of cochlear implants for children and adults with severe to profound deafness, and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of cochlear implants. Closing date for comments is 8th April 2008.
Click here for the Consultation
Prophylaxis against infective endocarditis – Clinical Guideline CG64 (17th March 2008)
This guidance covers the protection of patients who are at risk of infective endocarditis, specifically adults and children or who have previously had infective endocarditis. It also covers people at risk because of medical procedures.
Click here for the NICE Guidance
Click here for the Appendices
Click here for the Quick Reference Guide
Click here for Understanding NICE
No comments:
Post a Comment